Vancomycin HCI IV bags recalled for labeling issue
Denver Solutions is recalling 33,480 Vancomycin HCI IV bags (NDC 71449-028-68) due to a labeling issue. The affected lots were distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses, injuries, or deaths. The stated issue is a labeling problem. Per the rubric, FDA Class III recalls are typically scored 1 or 2, and this qualifies as a 'minor labeling error' at severity level 2.
Plain-English summary
Denver Solutions, LLC, is recalling 33,480 Vancomycin HCI PF 1.25 g in 0.9% Sodium Chloride 250 mL IV bags (NDC 71449-028-68) due to a labeling issue. The product was manufactured by Leiters Compounding Health at 13796 Compark Blvd, Englewood, Colorado.
The recall involves a labeling classification issue. The specific nature of the labeling defect is not detailed in the available FDA recall information.
The affected product was distributed nationwide. Affected lot numbers include 2330781, 2330791, 2330795, 2330800, 2330807, 2330812, 2330816, 2330822, 2330897, 2330899, 2330901, 2330918, 2330943, 2331050, 2331064, and 2331102, with expiration dates ranging from October 2023 to January 2024.
Healthcare facilities and pharmacies that received affected lots should consult the FDA website or contact Denver Solutions for guidance on product handling and replacement.
The recalled product
- Product
- VANCOmycin HCI PF, 1.25 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only, Leiters Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-028-68.
- Manufacturer
- Denver Solutions, LLC DBA Leiters Health
- Category
- Drug — Antibiotic / Injectable
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot#: 2330781
- Exp. 10/19/23
- 2330791
- Exp. 10/29/23
- 2330795
- Exp. 11/02/23
- 2330800
- Exp. 11/09/23
- 2330807
- Exp. 11/11/23
- 2330812
- Exp. 11/16/23
- 2330816
- Exp. 11/19/23
- 2330822
- 10/20/23
- 2330897
- 11/23/23
- 2330899
- 11/25/23
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27